Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Makers LaboratoriesBOM:506919 -0.53%68 Days Inventory is 276.38 as of Mar. 2026, which is 78% above its 10-year median of 154.96. GuruFocus rates BOM:506919 with a GF Score™ of 68/100 and a GF Value™ of ₹174.67 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 923 Drug Manufacturers companies, Makers Laboratories ranks worse than 68.69% on this metric.
The historical rank and industry rank for Makers Laboratories's Days Inventory or its related term are showing as below:
BOM:506919'
s Days Inventory Range Over the Past 10 Years
Min: 71.22 Med: 154.96 Max: 218.1
Current: 218.1
During the past 13 years, Makers Laboratories's highest Days Inventory was 218.10. The lowest was 71.22. And the median was 154.96.
BOM:506919's Days Inventory is ranked worse than 68.69% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.87
vs BOM:506919: 218.10
Makers Laboratories's Days Inventory
increased
from Mar. 2025 (222.26) to Mar. 2026 (276.38).
It might indicate that Makers Laboratories's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Makers Laboratories's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.33.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Makers Laboratories's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.26.
Makers Laboratories (BOM:506919) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Makers Laboratories's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Makers Laboratories's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Makers Laboratories Days Inventory Related Terms
Makers Laboratories Days Inventory Historical Data
* Premium members only.
The historical data trend for Makers Laboratories's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Makers Laboratories's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Makers Laboratories Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Makers Laboratories's Days Inventory distribution charts can be found below:
* The bar in red indicates where Makers Laboratories's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Makers Laboratories (BOM:506919) has a Days Inventory of 276.38 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Makers Laboratories and its competitors. This is 78% above median its historical median of 154.96. Over the past decade, Makers Laboratories' Days Inventory has ranged from 71.22 to 218.10. According to the industry distribution chart, Makers Laboratories ranks #634 out of 923 companies in the Drug Manufacturers industry, placing it in the top 68.7%.
Is Makers Laboratories' Days Inventory too high?
Makers Laboratories' current Days Inventory of 276.38 is 78% above median its 10-year median of 154.96. Over the past 10 years, this metric has ranged from a low of 71.22 to a high of 218.10. The Drug Manufacturers industry median Days Inventory is 164.87. Makers Laboratories' value of 276.38 is 67.6% above this industry median. Based on the distribution chart, Makers Laboratories ranks #634 out of 923 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Makers Laboratories has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Makers Laboratories' Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Makers Laboratories ranks #634 out of 923 companies for Days Inventory. This places Makers Laboratories in the lower half of its industry. The industry median Days Inventory is 164.87. Makers Laboratories' value of 276.38 is 67.6% above this benchmark. Historically, Makers Laboratories' own Days Inventory has ranged from 71.22 to 218.10 over the past decade. While the company's 10-year median is 154.96 vs. the industry median of 164.87, Makers Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.87, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Makers Laboratories's current Days Inventory of 276.38 is 67.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Makers Laboratories and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Makers Laboratories's current Days Inventory is 276.38, which is 78% above median its own 10-year median of 154.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Makers Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Makers Laboratories (BOM:506919) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹174.67, compared to a current price of ₹151.50 — trading 13.3% below its estimated fair value. The current Days Inventory is 276.38, which is 78% above median its 10-year median of 154.96 and 67.6% above the Drug Manufacturers industry median of 164.87. Makers Laboratories' overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Makers Laboratories (BOM:506919), the current Days Inventory is 276.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Makers Laboratories (BOM:506919) Overvalued in 2026?
Based on GuruFocus' analysis, Makers Laboratories stock appears to be undervalued.
The current stock price of ₹151.50 is trading 13.3% below its estimated GF Value™ of ₹174.67.
GuruFocus considers Makers Laboratories to be Modestly Undervalued.
Key valuation signals for BOM:506919:
Days Inventory: 276.38 (78% above median its 10-year median of 154.96)
GF Value™: ₹174.67 vs. price of ₹151.50 (13.3% below fair value)
Industry Position: 67.6% above the Drug Manufacturers median (#634 of 923)
No single metric tells the full story. See the BOM:506919 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Makers Laboratories Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of pharmaceutical products. The company's product portfolio includes Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (Anti-Cough Range), and Exylin (Amoxycillin range), among others. The reportable segment of the company is the Pharmaceutical segment.
68GF Score
Get the complete analysis for BOM:506919
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:506919 has been successfully added to your 
